Data Management at Geneuity
Effective data management is crucial in the fast-paced world of clinical trials. At MPLN, our journey through data management has evolved significantly since our first clinical trial in 2004.
Explore the latest trends in biopharma, from innovations in cancer diagnostics to advancements in therapies for blood disorders. Stay informed on cutting-edge research and industry news.
Effective data management is crucial in the fast-paced world of clinical trials. At MPLN, our journey through data management has evolved significantly since our first clinical trial in 2004.
The realm of clinical trials is continuously evolving, with digital pathology emerging as a transformative force. By shifting from traditional glass slides to digital counterparts, clinical trials are witnessing unprecedented efficiency, cost savings, and enhanced data management. Here’s a deep dive into the myriad benefits that digital pathology brings to the table.
Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced that Molecular Pathology Laboratory Network, Inc. (MPLN) is now the first national molecular reference laboratory to verify and launch oncoReveal™ CDx.
For myelodysplastic syndromes, current therapy is selected based on risk, transfusion needs, percent of bone marrow blasts, cytogenetic and mutational profiles, comorbidities, potential for allogeneic stem cell transplantation (alloSCT), and prior exposure to hypomethylating agents (HMA). Better diagnosis and prognostic stratification may allow a more precise and personalized treatment of MDS with novel agent combinations, […]
Beyond informing drug target discovery, validation, and clinical development, it uncovers critical genetic markers that drive disease progression and influence individual treatment responses. This empowers healthcare professionals to create more precise, tailored treatment plans, optimizing medical management based on each patient’s genetic profile.
DNA Solutions – WGS*, WGMS*, WES*, TSO-500 Comp, Pillar OncoReveal
RNA Solutions – Total RNA-Seq*, RNA exome*, mRNA*
Liquid Biopsy Solutions – TSO-500 ctDNA, PGDx elio™ plasma complete*
*Offered through fully accredited partner laboratories.
Our advanced technology enables simultaneous visualization of single or multiple biomarkers within the same tissue section, delivering comprehensive insights and precise diagnostics. With unmatched expertise and cutting-edge technology, our team supports you in understanding complex tissue microenvironments, aiding patient stratification and treatment response prediction.